{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "(NM_001126112.3:r.1441C)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant"
        },
        {
          "HGVS": "(NM_001126112.3:g.2019S)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant"
        },
        {
          "HGVS": "(NM_001126112.3:i.2020T)",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005784"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay and pull-down experiments",
      "Material used": {
        "Material Source": "Cell lines and primary cultures",
        "Material Name": "Human cells (e.g., PC1, MIA20-V)",
        "Description": "Cells were transfected with wild-type or mutant LRRK2 protein."
      },
      "Readout type": "Immunoblotting for phosphorylated Akt1",
      "Readout description": [
        {
          "Variant": "(NM_001126112.3:r.1441C)",
          "Conclusion": "Phosphorylation was observed at Ser1441",
          "Molecular Effect": "Partial loss of Akt1 phosphorylation",
          "Result Description": "Immunoblot showed reduced phosphorylation at serine 1441 (R variant)"
        },
        {
          "Variant": "(NM_001126112.3:g.2019S)",
          "Conclusion": "Phosphorylation was observed at Ser2019",
          "Molecular Effect": "Partial loss of Akt1 phosphorylation",
          "Result Description": "Immunoblot showed reduced phosphorylation at serine 2019 (G variant)"
        },
        {
          "Variant": "(NM_001126112.3:i.2020T)",
          "Conclusion": "Phosphorylation was observed at Ser2020",
          "Molecular Effect": "Partial loss of Akt1 phosphorylation",
          "Result Description": "Immunoblot showed reduced phosphorylation at serine 2020 (I variant)"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Three biological replicates were performed.",
        "Description": "Data averaged from three independent cell populations."
      },
      "Technical replicates": {
        "Technical replicates": "Each experiment was repeated with identical controls.",
        "Description": "All immunoblot experiments were performed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein served as the positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-target constructs were used to establish baseline phosphorylation levels."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Two LP constructs were validated for proper LRRK2 kinase activity.",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "One LB construct was used to confirm baseline Akt1 phosphorylation levels.",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed t-test (unpaired) for comparing phosphorylation ratios."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylated Akt1 protein levels greater than 20% in immunoblot.",
        "Source": "Custom analysis"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylated Akt1 protein levels less than 5% in immunoblot.",
        "Source": "Custom analysis"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}